Clinical Trials Directory

Trials / Conditions / Recurrent Brain Neoplasm

Recurrent Brain Neoplasm

18 registered clinical trials studyying Recurrent Brain Neoplasm — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingUse of Shear Wave Elastography for Intraoperative Brain and Tumor Stiffness Measurements
NCT06630338
Mayo Clinic—
TerminatedComparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery
NCT04588246
NRG OncologyPhase 3
CompletedSTAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma
NCT01904123
M.D. Anderson Cancer CenterPhase 1
CompletedBlood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery
NCT03071913
Mayo Clinic—
CompletedAnti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16
NCT02658981
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1
RecruitingElectrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
NCT02754544
M.D. Anderson Cancer CenterN/A
Active Not RecruitingRadiation Therapy in Treating Patients With Recurrent Brain Tumors Who Have Undergone Previous Radiation Thera
NCT02698254
M.D. Anderson Cancer CenterN/A
CompletedAutologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
NCT02661282
M.D. Anderson Cancer CenterPhase 1 / Phase 2
CompletedSelinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
NCT02323880
Children's Oncology GroupPhase 1
Active Not RecruitingDasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Sol
NCT02389309
M.D. Anderson Cancer CenterPhase 1
WithdrawnEGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
NCT02521090
Barbara Ann Karmanos Cancer InstitutePhase 1 / Phase 2
Active Not RecruitingPembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diff
NCT02359565
National Cancer Institute (NCI)Phase 1
CompletedPalliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
NCT02575027
Jonsson Comprehensive Cancer CenterN/A
Active Not RecruitingComputer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy
NCT01503086
Children's Oncology GroupN/A
Completed18F-DOPA-PET in Planning Surgery in Patients With Gliomas
NCT02020720
Mayo ClinicEARLY_Phase 1
Completed18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors
NCT02167204
University of WashingtonN/A
CompletedVaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
NCT01250470
Roswell Park Cancer InstitutePhase 1
CompletedBevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
NCT01609790
National Cancer Institute (NCI)Phase 2